The U.S. home infusion therapy market is projected to grow from USD 19.56 billion in 2025 to USD 36.88 billion by 2034, with a CAGR of 7.3%. This growth is driven by the rising prevalence of chronic diseases like cancer and diabetes, a growing aging population, and a shift toward cost-effective, patient-centric healthcare. Home infusion therapy allows patients to receive vital treatments like antibiotics, chemotherapy, and hormone therapy in the comfort of their homes. Technological advancements, improved home care infrastructure, and expanding product segments such as infusion pumps and needleless connectors are further fueling this market.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5102
Market Trends
Rise in Chronic Disease Management at Home
● Increasing use of home infusion therapy for cancer, diabetes, and infections.
● Enhances patient comfort, reduces hospital visits.
Technological Advancements
● Smart infusion pumps, remote monitoring, and portable devices improve care and safety.
● Innovation in elastomeric pumps boosts adoption for OPAT and chemotherapy.
Strategic Collaborations and Expansions
● GC Biopharma partnered with AOM Infusion for ALYGLO distribution (Nov 2024).
● Shields Health Solutions expanded specialty pharmacy with UnityPoint (July 2024).
Regulatory Approvals
● Eisai and Biogen’s subcutaneous Alzheimer’s therapy LEQEMBI approved in Jan 2025.
● Duke Home Infusion Pharmacy opened in April 2025 to support local care expansion.
Market Insights
● Infusion Pumps Dominated: 43% market share in 2023.
● Cancer & Diabetes: Responsible for 36% of the market demand in 2023.
● Anti-infective Applications: Held the largest market share by application in 2024.
● Endocrinology: Fastest-growing application segment due to diabetes surge.
● 3.2 million Americans currently receive home infusion therapy annually (NHIA).
Market Dynamics
Drivers
Increasing Cancer & Diabetes Cases
Chronic illnesses need long-term treatment that home infusion supports.
Aging U.S. Population
More seniors require home-based treatment solutions.
Cost Reduction for Patients and Facilities
Reduces inpatient stay, hospital-acquired infections, and insurance expenses.
Technological Innovation
Portable pumps, smart devices, and remote care increase adoption.
Challenges
Healthcare Policies and Reimbursement Gaps
Current U.S. regulations still favor hospital-based treatments.
Knowledge Gap Between Clinicians & Home Care Providers
Can lead to inconsistent outcomes if not bridged.
Regional Segments
United States (Developed Region Focus)
● High adoption due to:
● Aging population
● Advanced home healthcare infrastructure
● Shift toward patient-centric care
● ~3.2 million patients currently use home infusion services (NHIA, 2024)
Western Europe (Comparative Growth)
● Similar trends observed due to public healthcare models favoring home care.
Segment Highlights
By Product
Infusion Pumps (Largest Share, 2024)
● Includes ambulatory, volumetric, PCA, syringe, and elastomeric pumps.
● Smart pump tech improves dosage safety and user alerts.
Needleless Connectors (Fastest Growing)
● Reduces infection risks and provides safer IV access.
By Application
Anti-Infective (Largest Share, 2024)
● Used for pneumonia, sepsis, herpes, etc.
● Enables severe infection treatment at home.
Endocrinology (Fastest Growing Segment)
●Driven by rising diabetes rates (589 million globally in 2024, IDF).
●Includes insulin, testosterone, and hormone infusion therapy.
Top Companies 2025
● Option Care Health, Inc.
● B. Braun Medical, Inc.
● Baxter International Inc.
●Fresenius Kabi USA
● Amedisys, Inc.
● CareCentrix, Inc.
● ICU Medical
● Smiths Medical, Inc.
● CareFusion
● Caesarea Medical Electronics Ltd.
Top 5 FAQs
1. What is home infusion therapy and why is it growing in the U.S.?
Answer: Home infusion therapy is the administration of medications via IV at a patient’s home. It’s growing due to increased chronic diseases, cost savings, convenience, and better technology.
2. Which product segment leads the U.S. home infusion market?
Answer: Infusion pumps dominate the market due to their essential role in delivering medications, especially portable and smart pumps.
3. What are the main applications of home infusion therapy?
Answer: Key applications include anti-infectives, endocrinology (diabetes/hormonal therapy), chemotherapy, and nutrition support (enteral/parenteral).
4. What challenges does the home infusion market face?
Answer: The main hurdles are outdated healthcare reimbursement policies favoring hospital treatments and limited clinical training for home infusion practices.
5. How are technological innovations impacting the market?
Answer: Devices like elastomeric pumps and remote monitoring tools enhance patient experience, safety, and adherence, encouraging broader adoption.
● Check out below
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5102
Access our exclusive, data-rich dashboard dedicated to the medical devices – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About the Author
